Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2385]

New marker, new target in Ewing's sarcoma

New marker, new target in Ewing's sarcoma

Enzalutamide submitted for EMEA authorisation for advanced prostate cancer post-chemotherapy

Enzalutamide submitted for EMEA authorisation for advanced prostate cancer post-chemotherapy

Trial launched into testosterone replacement for male cancer survivors

Trial launched into testosterone replacement for male cancer survivors

Progress in quest to reduce use of radiation in treatment of paediatric Hodgkin lymphoma

Progress in quest to reduce use of radiation in treatment of paediatric Hodgkin lymphoma

Metformin may lower cancer risk in people with type 2 diabetes

Metformin may lower cancer risk in people with type 2 diabetes

Treating radiation poisoning by targeting the thrombomodulin–activated protein C pathway

Treating radiation poisoning by targeting the thrombomodulin–activated protein C pathway

Misidentified and contaminated cell lines lead to faulty cancer science

Misidentified and contaminated cell lines lead to faulty cancer science

EHA 17: Malignant cells in patients with chronic lymphocytic leukaemia escape T cell recognition and attack

EHA 17: Malignant cells in patients with chronic lymphocytic leukaemia escape T cell recognition and attack

EHA 17: Evaluation of a single iron dose as ferric carboxymaltose (FCM) for fatigue treatment in iron deficient women

EHA 17: Evaluation of a single iron dose as ferric carboxymaltose (FCM) for fatigue treatment in iron deficient...

Mutations in KRAS lead to acquired resistance to anti-EGFR therapy in colorectal cancer

Mutations in KRAS lead to acquired resistance to anti-EGFR therapy in colorectal cancer

More from ecancer